171
Participants
Start Date
February 18, 2016
Primary Completion Date
February 23, 2021
Study Completion Date
March 25, 2021
Nilotinib
A daily dose of 300 mg was given to all participants as two 150 mg capsules BID. The prescription of study drug was not study dependent and followed medical needs of the participant only. The study treatment was administered for 24 months.
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Bad Saarow
Novartis Investigative Site, Rostock
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Oldenburg
Novartis Investigative Site, Wilhelmshaven
Novartis Investigative Site, Westerstede
Novartis Investigative Site, Rotenburg (Wümme)
Novartis Investigative Site, Bremerhaven
Novartis Investigative Site, Hanover
Novartis Investigative Site, Hanover
Novartis Investigative Site, Minden
Novartis Investigative Site, Paderborn
Novartis Investigative Site, Kassel
Novartis Investigative Site, Giessen
Novartis Investigative Site, Wolfsburg
Novartis Investigative Site, Goslar
Novartis Investigative Site, Halberstadt
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Velbert
Novartis Investigative Site, Herne
Novartis Investigative Site, Essen
Novartis Investigative Site, Essen
Novartis Investigative Site, Mülheim
Novartis Investigative Site, Moers
Novartis Investigative Site, Münster
Novartis Investigative Site, Georgsmarienhütte
Novartis Investigative Site, Cologne
Novartis Investigative Site, Aschaffenburg
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Bad Soden
Novartis Investigative Site, Saarbrücken
Novartis Investigative Site, Worms
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Göppingen
Novartis Investigative Site, Mutlangen
Novartis Investigative Site, Schorndorf
Novartis Investigative Site, Schwäbisch Hall
Novartis Investigative Site, München
Novartis Investigative Site, Bad Reichenhall
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Donauwörth
Novartis Investigative Site, Memmingen
Novartis Investigative Site, Biberach
Novartis Investigative Site, Nuremberg
Novartis Investigative Site, Nuremberg
Novartis Investigative Site, Passau
Novartis Investigative Site, Bayreuth
Novartis Investigative Site, Bamberg
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Schweinfurt
Novartis Investigative Site, Bad Mergentheim
Novartis Investigative Site, Erfurt
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Dresden
Novartis Investigative Site, Halle
Novartis Investigative Site, Halle S
Novartis Investigative Site, Jena
Novartis Investigative Site, Leipzig
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY